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Abstract
Background: In 1998, mandatory folic acid fortification of white flour and select cereal grain products was
implemented in Canada with the intention to increase dietary folate intakes of reproducing women. Folic acid
fortification has produced a dramatic increase in blood folate concentrations among reproductive age women,
and a reduction in neural tube defect (NTD)-affected pregnancies. In response to improved blood folate
concentrations, many health care professionals are asking whether a folic acid supplement is necessary for NTD
prevention among women with high blood folate values, and how reliably high RBC folate concentrations predict
folate intakes shown in randomized controlled trials to be protective against NTDs. The objective of this study
was to determine how predictive blood folate concentrations and folate intakes are of each other in a sample of
well-educated lactating Canadian women exposed to high levels of synthetic folate.
Methods: The relationship between blood folate concentrations and dietary folate intakes, determined by
weighed food records, were assessed in a sample of predominantly university-educated lactating women (32 ± 4
yr) at 4-(n = 53) and 16-wk postpartum (n = 55).
Results: Median blood folate concentrations of all participants were well above plasma and RBC folate cut-off
levels indicative of deficiency (6.7 and 317 nmol/L, respectively) and all, except for 2 subjects, were above the cut-
off for NTD-risk reduction (>906 nmol/L). Only modest associations existed between total folate intakes and
plasma (r = 0.46, P < 0.001) and RBC (r = 0.36, P < 0.01) folate concentrations at 16-wk postpartum. Plasma and
RBC folate values at 16-wk postpartum correctly identified the quartile of folate intake of only 26 of 55 (47%) and
18 of 55 (33%) of subjects, respectively. The mean RBC folate concentration of women consuming 151–410 µg/
d of synthetic folate (2nd quartile of intake) did not differ from that of women consuming >410 µg/d (3rd and 4th
quartile).
Conclusion: Folate intakes, estimated by food composition tables, and blood folate concentrations are not
predictive of each other in Canadian lactating women exposed to high levels of folate. Synthetic intakes > 151–
410 µg/d in these women produced little additional benefit in terms of maximizing RBC content. More studies are
needed to examine the relationship between blood folate concentration and NTD risk. Until data from such
studies are available, women planning a pregnancy should continue to consume a daily folic acid supplement of
400 µg.
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Folic acid supplementation during the periconceptional
period is effective in reducing the risk of neural tube
defects (NTDs) [1-5]. However, the proportion of Cana-
dian women that report consuming a folic acid-contain-
ing supplement during the periconceptional period is low
ranging between 17 – 28% [6-9]. Similar rates are docu-
mented even among women who are knowledgeable
about the health benefits of consuming folic acid during
this life-stage [8]. As a result, mandatory folic acid fortifi-
cation of white flour and select cereal grain products was
implemented in 1998 in Canada with the intention to
increase the dietary folate intakes of reproducing women
by 80 to 100 µg/d [10]. Indeed folic acid fortification has
resulted in a dramatic increase in blood folate concentra-
tions in North America, and a significant reduction in
NTD-affected pregnancies (19 – 78%) [7,11-14].
In response to the improved blood folate concentrations
of reproductive age women, many health care profession-
als are requesting direction on how aggressively they
should promote folic acid supplementation among
patients with high blood folate concentrations during the
periconceptional period. The research literature shows
many Canadian women post-fortification have red blood
cell (RBC) folate concentrations approaching or exceed-
ing 906 nmol/L [7,15], a value in early pregnancy shown
to be an indicator of a reduced risk for NTDs [16-18]. For
example, we previously reported median RBC folate con-
centrations ≥ 3000 nmol/L during the 3rd trimester of
pregnancy in a sample of well-educated Canadian women
[15].
It must be acknowledged that the body of evidence sup-
porting a relationship between folic acid supplementation
during the periconceptional period and the risk of an
NTD-affected pregnancy is considerably more robust than
that of the association between blood folate concentra-
tions and NTD risk [1-5,19]. Nonetheless, it is hard to
argue against the logic that RBC folate concentrations, a
measure of tissue folate stores, are unlikely to be elevated
unless dietary folate intakes are similarly high [20]. For
example, in controlled feeding studies preceded by a
folate depletion phase of 2–7 weeks, serum and RBC
folate concentrations of reproductive age women reflect
the folate content of their diet (folate depletion, 400, 800
µg/day dietary folate equivalents [DFE]) [21-25]. Pre-folic
acid fortification of the food supply, we reported a weak
association between RBC folate concentrations and die-
tary folate intakes in young women not consuming a folic
acid-containing supplement (r = 0.23, P < 0.05) [26]. This
association improved when young women consuming
supplemental folic acid were included in the analyses (r =
0.50, P < 0.01), suggesting that as the proportion of folate
intake from synthetic folic acid increases, so might the
predictive value of blood folate measures in determining
folate intake. We speculated that folic acid added as a for-
tificant to food may likewise strengthen this association
given its stability, and improved precision and accuracy of
measurement, compared to endogenous folates which are
normally trapped within cellular matrices, and need to be
converted to a microbiologically assayable form. Second,
inclusion of women known to consume supplements and
fortified foods is likely to increase the range of exposure to
folate which may also strengthen the association between
blood folate concentration and folate intake. In contrast,
if the relationship between blood folate concentration
and folate intake is no longer linear at higher levels of
exposure or the quality of the food composition tables has
deteriorated given the variability in mandated versus
actual levels of folic acid fortification, the association
between blood folate concentration and dietary folate
intake may not have improved.
Lactation is an opportune time to investigate the predic-
tive value of blood folate concentrations in determining
dietary folate intake as (1) women are clearly at a repro-
ductive stage of their life cycle; (2) requirements for folate
are elevated [27]; (3) vitamin supplement use is common.
Therefore, the objective of this study was to examine
whether, or not, blood folate concentrations, and dietary
and synthetic folic acid intakes are predictive of each other
in a sample of affluent, well-educated lactating women




The dietary folate data and blood folate concentrations
presented for the observational study presented herein
were collected as part of a prospective, randomized con-
trol trial designed to assess the efficacy of supplemental
[6S]-5-methyltetrahydrofolate ([6S]-5-methylTHF) versus
folic acid during lactation (n = 69). A detailed description
of the study design, procedures and information on the
precision and reproducibility of laboratory procedures
can be found elsewhere [15]. Briefly, participants were
recruited between April 2002 and December 2003. Preg-
nant women (<36 wk gestation) were eligible for the over-
all study if they were healthy, non-smoking, between the
ages of 16 to 40 years and intended to exclusively breast-
feed for greater than 4 months postpartum. Subjects were
identified by word-of-mouth and through the Motherisk
Program, a telephone counseling service, at the Hospital
for Sick Children, Toronto, Canada. The Human Ethics
Committee of The Hospital for Sick Children approved
the study and it was conducted in accordance with the
policies and procedures of this institution and the Cana-
dian Tri-Council policy statement on ethical conduct ofPage 2 of 8
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written, informed consent.
Study Design
At baseline (36 wk gestation), women were enrolled and
a self-administered questionnaire was given to collect
information on household income and education level.
Participants were then given instructions on the comple-
tion of 3-d weighed food records and blood samples were
collected. Three-d weighed food records and additional
blood samples were collected at 4- and 16-wk postpartum
(± 1 wk).
In the overall study, women were assigned to receive
either a folate supplement (~400 µg/d of [6S]-5-methyl-
THF or folic acid) or a placebo within one week of deliv-
ery. Subjects were instructed to consume the study
capsules daily until 16-wk postpartum and to avoid con-
suming any other folate-containing supplement during
the intervention period. In addition all subjects received a
daily folate-free multivitamin and mineral supplement,
which contained 1 mg vitamin B6, 3 µg vitamin B12 and
4 mg ferrous fumarate (Exact; Pharmetics, Quebec, Can-
ada).
Laboratory procedures
Blood samples for the analysis of plasma and RBC folate
were collected in EDTA-treated tubes at 36 wk gestation
and at 4- and 16-wk postpartum. Plasma folate concentra-
tion is an indicator of recent dietary and supplemental
folate intake whereas RBC folate concentration is reflec-
tive of tissue folate stores [20]. Hematocrit was measured
immediately using freshly collected blood with the use of
an electronic hematology analyzer (HmX, Beckman Coul-
ter, Miami, Florida). Aliquots (100 µl) of whole blood
were diluted 10-fold with ascorbic acid and ddH2O (1%
wt:vol) and incubated at 37°C to allow for the deconjuga-
tion of folate. Plasma folate and RBC folate concentra-
tions were measured by microbiological assay as
described by Molloy and Scott [29]. Plasma homocysteine
was measured by high performance liquid chromatogra-
phy (HPLC) with electrochemical detection according the
method of Cole et al. [30].
Dietary Folate Assessment
Dietary folate intakes were estimated using 3-d weighed
food records. Diet records were completed over 2 non-
consecutive days and 1 weekend day by study participants
who were trained by 1 of 2 registered dietitians on how to
complete food records using an electronic digital scale
accurate to 1 g (CS2000; Ohaus Corporation, Pine Brook,
NJ). Dietary folate intakes were then tabulated from the
diet records using Health Canada's Canadian Nutrient File
(CNF), version 2001 b [31] which has been updated to
reflect current mandated Canadian fortification levels and
is based on the USDA Nutrient Database for Standard Ref-
erence [32]. The CNF reports dietary folate as (1) total die-
tary folate (µg) (sum of naturally occurring folate and
folic acid added as fortificant) and (2) folic acid (µg), as a
fortificant, separately. Supplemental folate intakes were
determined by assessing the difference between the
number of capsules dispensed at randomization (within 1
week postpartum) and number of capsules remaining at
study completion (16-wk postpartum).
Statistical Analysis
SAS for WINDOWS (version 9.1; SAS Institute Inc, Cary,
NC) was used for statistical analyses and a probability
level of 5% was chosen as the level of statistical signifi-
cance. The large intra-subject variance in folate intakes
were removed using SIDE: Software for Intake Distribu-
tion Estimation (version 1.0, Dept of Statistics and Center
for Agricultural and Rural Development, Iowa State Uni-
versity, Iowa). The SIDE program operates within SAS for
WINDOWS, and generates an estimate of subjects' usual
(long-term average) intake by using the distribution of
their observed intakes and partially removing the day-to-
day variation in individuals' intakes.
Blood folate concentrations were normalized using loga-
rithmic transformations. Partial correlations (r) were gen-
erated between plasma and RBC folate concentrations and
folate intakes (total folate and synthetic folate, sepa-
rately). In addition, the association between RBC folate
concentrations at 16-wk postpartum and synthetic folate
intake (by quartile assignment for each) was investigated
using a one-way analysis of variance and Tukey multiple
comparison procedures. RBC folate concentrations meas-
ured at study recruitment (36 wk gestation) and the form
of folate supplement consumed (e.g. [6S]-5-MTHF, folic
acid or placebo) during the intervention were entered as
covariates in these latter analyses.
The effectiveness of using blood folate values to correctly
classify folate intakes was assessed by comparing the quar-
tile assignments for (1) dietary folate intake (total and
synthetic folate) and (2) blood folate concentration
(plasma and RBC folate) of each subject. When dietary
and blood values were assigned to the same quartile, it
was concluded that the blood folate value for that subject
correctly classified their dietary folate intake. Dietary
folate intakes misclassified by only one quartile were con-
sidered closely classified, and those misclassified by two
or more quartiles were considered misclassified. If no
association existed between the assigned quartile of blood
folate concentration and dietary folate intake, one would
expect 25% of participants to be correctly classified,
37.5% to be closely classified and 37.5% to be misclassi-
fied. The actual number of subjects assigned to each quar-Page 3 of 8
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chi-square goodness of fit test with 2 degrees of freedom.
Total dietary folate intakes are expressed in the manu-
script, except where indicated, as "Dietary Folate Equiva-
lents" [µg/d DFE = natural folate, µg + (1.7 × of
supplemental folate, µg)] to adjust for the greater bioa-
vailability of synthetic (added as a fortificant or supple-
mental) folate relative to endogenous sources [27]. For
ease of interpretation, no adjustment was made to
account for bioavailability of synthetic folate intakes




Only those subjects from the overall study who completed
3-d weighed food records and had provided a concomi-
tant blood sample for folate analysis were included in the
present analyses (4-wk postpartum, n = 53; 16 wks post-
partum, n = 55). The mean age of the participants at
enrollment was 32.2 ± 3.8 y (mean ± SD). Participants
were well-educated (51 of 55 had completed college or
university) and predominantly from households with
incomes > $75,000 per annum. In Ontario, the mean
household income in 2001 was estimated be $60,500
[33]. Prenatal supplements containing folic acid were
used by 98% (54 of 55) participants during the course of
their pregnancy. The average amount of folic acid pro-
vided by the supplements prenatally was 923 ± 239 µg/d.
Biochemical indexes
Median blood folate concentrations during lactation were
well above plasma and RBC folate cut-off levels indicative
of deficiency (6.7 and 317 nmol/L, respectively) [34]
(Table 1). In fact, even by 16-wk lactation, only two of the
women had RBC folate values below 906 nmol/L, the
value early in pregnancy shown to be an indicator of
reduced risk of NTD. RBC folate concentrations of these
two subjects were 869 nmol/L and 822 nmol/L at 16-wk
postpartum. Neither woman consumed a folate supple-
ment during lactation.
Moderate statistically significant correlations (r = 0.46–
0.49, P < 0.001) were found between total (µg DFE) and
synthetic folate intakes (µg) and plasma folate concentra-
tions at 4- and 16-wk postpartum (Table 2). Weak, but sta-
tistically significant correlations (r = 0.31–0.36), were
found between total (µg DFE) and synthetic folate intakes
(µg) at 4- and 16-wk postpartum and RBC folate concen-
trations. Regardless of whether, or not, comparisons of
folate intake were made with plasma or RBC folate con-
centration, the strength of the association between syn-
thetic folic acid intake and blood folate values did not
differ from the association when all sources of folate
intake were considered in the analyses (i.e. naturally
occurring + synthetic).
At 16-wk postpartum, plasma and RBC folate concentra-
tions enabled correct prediction of the folate intake quar-
tile assignment for only 47 and 33% of subjects,
respectively (Table 3). Further, the percentage of partici-
pants correctly classified into their quartile of folate intake
by plasma and RBC folate concentration diminished with
the removal of supplement users.
Mean RBC folate concentrations were plotted by the quar-
tile of synthetic folic acid intake among lactating
women16-wk postpartum to ascertain the mean RBC
folate concentration consistent with supplemental folate
intakes at or above 411 ug/d – the top two quartiles of
synthetic folic acid intake (Figure 1). Given that women
Table 1: Measures of folate status and estimation of folate intakes at 4 and 16 wk postpartum1
Daily folate supplementation
Variable 0 µg 400 µg
4 wks (n = 17) 16 wks (n = 18) 4 wks (n = 36) 16 wks (n = 37)
Plasma folate (nmol/L) 59 (41, 85) 46 (29, 63) 110 (74, 143) 93 (71, 120)
RBC folate (nmol/L) 2190 (1875, 2626) 1374 (1025, 1692) 3024 (2313, 3992) 2090 (1641, 2527)
% > 906 nmol/L2 100 89 100 100
Plasma homocysteine (µmol/L) 8.8 (8.1, 9.6) 8.7 (8.0, 9.4) 9.2 (8.6, 9.8) 8.9 (8.2, 9.6)
Dietary folate intake
Synthetic folate, µg/d3 147 (75, 174) 118 (87, 151) 472 (408, 511) 450 (410, 479)
Dietary folate, µg/d 225 (193, 322) 253 (208, 320) 271 (214, 331) 268 (217, 326)
Total folate, µg DFE/d 481 (400, 561) 467 (379, 543) 1072 (983, 1163) 1040 (953, 1135)
Abbreviations: DFE, dietary folate equivalent = (µg of natural dietary folate) + (µg of folic acid from fortification × 1.7) + (µg of folate from 
supplement × 1.7)
1 Median (1st, 3rd quartile); 2 RBC folate > 906 nmol/L is associated with low NTD risk [16]. 3 Synthetic folate = supplemental + folic acid as 
fortificantPage 4 of 8
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mean RBC folate concentrations comparable to those in
the upper two quartiles of folate intake suggests that the
synthetic folate intakes >151–410 ug/d exceed their
capacity to incorporate folate into erythropoiesis.
Discussion
Results from the present study suggest that blood folate
concentrations, and folate intake determined by food
composition tables, are not reliable predictors of each
other in a sample of Canadian lactating women exposed
to high levels of folate. In fact, plasma and RBC folate con-
centrations predicted the correct quartile of folate intake
of lactating women in our study less than half of the time.
Arguably the best evidence supporting a relationship
between folate and NTD-prevention comes from rand-
omized prevention trials in which women were assigned
to receive supplemental folic acid (± other vitamins and
minerals) during the periconceptional period compared
to those that were not [1,3-5]. Given the uncertainty of the
mechanism(s) of how folate reduces the risk of NTDs,
many health care professionals ask how well RBC folate
concentrations predict synthetic folic acid intake in order
to inform their decision on whether to recommend folic
acid supplementation to women with very high blood
folate concentrations. While it is conceivable that post-
folic acid fortification of the food supply RBC folate con-
centration may be a better predictor of NTD risk than esti-
mated folate intake, and that folic supplementation is no
longer necessary for women with high RBC folate concen-
trations, randomized controlled trials to confirming this
are unlikely to be conducted due to ethical considera-
tions. Other experimental approaches will need to be con-
sidered. These known uncertainties together with our data
illustrating that blood folate concentrations are not very
predictive of folate intake suggest it would be prudent for
women even with high blood folate concentrations to
consume a folic acid supplement during the periconcep-
tional period for NTD prevention.
Contrary to our original hypothesis, the strength of the
association between dietary folate intake, determined by
food composition tables, and blood folate concentrations
has not improved post-folic acid fortification of the food
Table 3: Percentage of participants correctly, closely or misclassified into quartiles of folate intake compared with classification by 
blood folate indexes
Variable n Correctly Classified Closely Classified1 Misclassified2 P value3
4 wks postpartum
Supplement users + nonusers
Plasma folate 53 28 44 28 0.1427
RBC folate 53 40 40 20 < 0.001
Unsupplemented
Plasma folate 17 18 41 41 0.2707
RBC folate 17 35 30 35 0.0588
16 wks postpartum
Supplement users + nonusers
Plasma folate 55 47 33 20 <0.0001
RBC folate 55 33 43 24 < 0.05
Unsupplemented
Plasma folate 18 6 50 44 <0.0001
RBC folate 18 22 39 39 0.7866
1 Percentage of participants misclassified by one quartile
2 Percentage of participants misclassified by two or more quartiles
3 A P-value < 0.05 indicates a rejection of the null hypothesis that there is no association between folate intakes and blood folate concentration 
based on the expectation that 25% of participants would be correctly classified, 37.5% closely classified and 37.5% misclassified. The actual numbers 
are compared with expected numbers using chi-square goodness of fit with 2 df.
Table 2: Correlations between folate intakes estimated from a 3-
day weighed food record vs. blood folate indexes
4 wks 16 wks
n r P-value n r P-value
Total folate1
Plasma folate 53 0.47 < 0.001 55 0.46 < 0.001
RBC folate 53 0.32 < 0.05 55 0.36 <0.01
Synthetic folate2
Plasma folate 53 0.47 < 0.001 55 0.49 < 0.0001
RBC folate 53 0.31 < 0.05 55 0.36 < 0.01
1 Total folate = (µg of natural dietary folate) + (µg of folic acid from 
fortification × 1.7) + (µg of folate from supplement × 1.7)
2 Synthetic folate = (µg of folate from supplement) + (µg of folic acid 
from fortification)Page 5 of 8
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lations between dietary folate intake, as determined by 3-
d weighed food records, and RBC folate, an indicator of
NTD risk, at 4- (r = 0.32, P < 0.05) and 16-wk (r = 0.36, P
< 0.01) postpartum were found. The strength of these
associations are very similar to those recently reported
between dietary folate intake, as assessed by an abbrevi-
ated folate-targeted food/supplement screening tool, and
RBC folate concentration, in a sample of women from
California (r = 0.32, P = 0.0001) [35]. Neither the correla-
tions reported in the present study nor those in the Cali-
fornia report are stronger than those we previously
reported pre-fortification in a group of young women
from Southern Ontario (r = 50, P < 0.01) [26].
There are at least two likely explanations for our observa-
tions. First, the relationship between folate intake and
blood folate concentration was no longer linear among
lactating women in our study who for the most part had
been chronically exposed to high levels of synthetic folate
(Figure 1). Second, the quality of the food composition
tables for folate is poor and, in fact their reflection of the
"actual" folate concentration in foods may have deterio-
rated given the variability in mandated versus the actual
levels of folic acid fortification. The actual folate content
of the food supply in Canada is unknown. In 1998 when
Health Canada mandated folic acid fortification of the
food supply, they incorporated into the legislation an
allowance for overages. In the U.S. where the food supply
is also fortified with folic acid, overages are estimated to
range from one to two times mandated levels [36-38]. In
addition, the endogenous folate content of foods as listed
in the version of the CNF used in our dietary analyses was
determined prior to the use of the contemporary trien-
zyme folate extraction procedure; hence the quality of the
folate values as listed in this database remains questiona-
ble and are very likely an underestimate of the true con-
tent of many foods. However, Han et al. too recently
reported weak correlations between dietary folate intake
and serum (r = 0.27) and RBC folate (r = 0.29) concentra-
tions among healthy South Korean women despite the
fact that they directly measured the folate content of most
folate-containing foods after trienzyme extraction [39].
Regardless of the poor predictive ability of blood folate
measures in assessing relative dietary folate intake in our
study, it is clear that RBC folate concentrations in this
group of affluent, well-educated lactating women are gen-
erally consistent with a reduction in risk of NTD (> 906
nmol/L) as proposed by Daly and colleagues [16]. Using
data from a large case-control study of 56,049 women,
Daly et al reported a greater than eightfold difference in
NTD risk between women with RBC folate concentrations
less than 340 nmol/L compared with those with levels of
906 nmol/L or higher (P < 0.001) [16]. In fact, only two
women in the present study had RBC folate concentra-
tions = 906 nmol/L at 16-wk postpartum; interestingly
both were not consuming a folate-containing vitamin
supplement during lactation. The RBC folate concentra-
tions of these two women were 869 and 822 nmol/L,
which is well above cut-off values for classic folate defi-
ciency (363 nmol/L) [20,34].
As reported elsewhere, however, approximately one-third
of this sample of lactating women had dietary folate
intakes (folate endogenous to food + folic acid as a fortif-
icant) below their estimated average requirement [40].
Assuming that folic acid is being added to the food supply
at mandated levels, the synthetic folate intakes of women
in the present study increased by 147 and 118 µg/d folate
at 4- and 16-wk postpartum, respectively, as a result of
folic acid fortification of the food supply. Together with
the blood folate values reported herein, these observa-
tions suggest that as lactation continues beyond 16-wks, a
greater proportion of women not consuming a folate sup-
plement may develop RBC folate concentrations = 906
nmol/L. Subsequent to initiation of this study, Health
Canada[41]., like the American Academy of Pediatrics
[42] extended their recommended length of exclusive
breastfeeding from 4–6 to 6 months (26 weeks). Thereaf-
ter, they recommend that infants receive complementary
foods with continued breastfeeding through the first 12
months of life. In the present study, no women consum-
ing a 400 µg/d folate supplement had a blood folate value
≤ 906 nmol/L or a folate intake below her estimated aver-
Mean RBC folate concentrations (± SD) by quartile of syn-th tic folate intake (  = 55) at 16 wk postpartumFigure 1
Mean RBC folate concentrations (± SD) by quartile of syn-
thetic folate intake (n = 55) at 16 wk postpartum. Compari-
sons were made using one-way analysis of variance 
controlled for baseline RBC folate concentration (36 weeks 
gestation) and form of supplement provided during lactation 
(placebo, [6S]-5-methyl-THF, folic acid), and Tukeys multiple 
comparison procedures.
Synthetic folate intake (ug/d)
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sample of women, there didn't appear to be an advantage
of synthetic folate intakes > 151–410 µg/d in terms of
maximizing RBC folate concentration. Considered
together, then, these data suggest among well-nourished
lactating women a folate supplement of 400 µg consumed
consistently on a daily basis maximizes RBC folate con-
tent, and strikes the right balance versus higher levels (eg.
1000 or 5000 µg/d) of meeting the estimate average folate
requirement of lactating women and not providing overly
excessive amounts of folate than can not be incorporated
into RBC precursors.
While these data are among the first to specifically assess
how predictive blood folate concentrations and folate
intakes are of each other post-folic acid fortification of the
food supply, in addition to the quality of food composi-
tion tables, there are other limitations in estimating folate
intake that must be acknowledged. Specifically, many
women, particularly those that are overweight or con-
cerned about their body weight, may under-report their
dietary intake [43-45]. In addition, weighed food records,
while generally regarded as the gold standard for deter-
mining dietary intakes may result in under-reporting of
nutrient intake due to subject burden. Under-reporting
and variability in measuring dietary intakes could have
significantly weakened the statistical associations between
folate intakes and blood folate concentrations in the
present study. Both of the aforementioned issues could be
of particular concern postpartum when many women
have heightened awareness of their body weight and are
busy with a new baby.
Finally, it should be noted that most lactating women in
this study, on the advice of their primary care physician,
consumed a 1000 µg/d supplement of folic acid during
pregnancy. Many used the same folate-containing supple-
ment prior to conception for NTD-prevention. While the
life span of a RBC is ~120 days and hence by 16-wk lacta-
tion should reflect dietary and supplemental folate
intakes during lactation, the contribution of liver folate
stores amassed prior to parturition in meeting the nutri-
tional requirements beyond 16 weeks of lactation could
be significant. The absence of an improvement in the
association between blood folate concentrations and
folate intake between 4 and 16 weeks lactation could
reflect this phenomenon. While the incremental increase
in liver folate stores secondary to ingestion of 1000 µg/d
of supplemental folic acid during pregnancy is not
known, visceral folate stores in the form of long-lived
pteroylpolyglutamate pools can be converted to pteroyl-
monoglutamates which can then be released into circula-
tion [46,47].
Conclusion
In this sample of affluent well-nourished lactating Cana-
dian women chronically exposed to high levels of folate,
plasma and RBC folate concentrations were poor predic-
tors of relative folate intake, estimated by food composi-
tion tables generally, and synthetic folic acid intake
specifically. Synthetic intakes > 151–410 µg/d in these
women produced little additional benefit in terms of max-
imizing RBC content. More studies are needed to examine
the relationship between blood folate concentration and
NTD risk. Until data from such studies are available,
women planning a pregnancy should continue to con-
sume a daily folic acid supplement of 400 µg.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
DLO and LAH were responsible for the design of the study
and wrote the manuscript. LAH and KLS recruited the sub-
jects and were responsible for the sample collection, labo-
ratory analysis and statistical analysis. All authors read
and approved the final manuscript.
Acknowledgements
We thank the Motherisk program at The Hospital for Sick Children for 
assisting with recruitment, Glynnis DuBois for lactation support, and the 
research nurses from the Clinical Investigation Unit for blood sample col-
lection. We are grateful to all the mothers who participated in this project. 
This study was funded by Merck KGaA, Darmstadt, Germany and the Nat-
ural Sciences & Engineering Research Council of Canada. LAH and KLS 
were funded by the Ontario Student Opportunity Trust Fund-The Hospital 
for Sick Children Scholarship Program and the Canadian Institute of Health 
Research Training Program in Clinical Nutrition.
References
1. MRC Vitamin Study Research Group: Prevention of neural tube
defects: results of the Medical Research Council Vitamin
Study.  Lancet 1991, 338(8760):131-137.
2. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao
P, Wong LY, Gindler J, et al.: Prevention of neural-tube defects
with folic acid in China. China-U.S. Collaborative Project for
Neural Tube Defect Prevention.  N Engl J Med 1999,
341(20):1485-1490.
3. Czeizel AE, Dudas I: Prevention of the first occurrence of neu-
ral-tube defects by periconceptional vitamin supplementa-
tion.  N Engl J Med 1992, 327(26):1832-1835.
4. Kirke PN, Daly LE, Elwood JH: A randomised trial of low dose
folic acid to prevent neural tube defects. The Irish Vitamin
Study Group.  Arch Dis Child 1992, 67(12):1442-1446.
5. Laurence KM, James N, Miller MH, Tennant GB, Campbell H: Dou-
ble-blind randomised controlled trial of folate treatment
before conception to prevent recurrence of neural-tube
defects.  Br Med J (Clin Res Ed) 1981, 282(6275):1509-1511.
6. French MR, Barr SI, Levy-Milne R: Folate intakes and awareness
of folate to prevent neural tube defects: a survey of women
living in Vancouver, Canada.  J Am Diet Assoc 2003,
103(2):181-185.
7. Liu S, West R, Randell E, Longerich L, O'Connor KS, Scott H, Crow-
ley M, Lam A, Prabhakaran V, McCourt C: A comprehensive eval-
uation of food fortification with folic acid for the primary
prevention of neural tube defects.  BMC Pregnancy Childbirth
2004, 4(1):20.Page 7 of 8
(page number not for citation purposes)
BMC Pregnancy and Childbirth 2007, 7:25 http://www.biomedcentral.com/1471-2393/7/258. Morin P, De Wals P, St-Cyr-Tribble D, Niyonsenga T, Payette H:
Pregnancy planning: a determinant of folic acid supplements
use for the primary prevention of neural tube defects.  Can J
Public Health 2002, 93(4):259-263.
9. Morin P, De Wals P, Noiseux M, Niyonsenga T, St-Cyr-Tribble D,
Tremblay C: Pregnancy planning and folic acid supplement
use: results from a survey in Quebec.  Prev Med 2002,
35(2):143-149.
10. Canada Gazette. Part II: Regulatory impact analysis statement,
SOR/98-550.  1998, 132:3029-3033.
11. Persad VL, Van den Hof MC, Dube JM, Zimmer P: Incidence of
open neural tube defects in Nova Scotia after folic acid forti-
fication.  CMAJ 2002, 167(3):241-245.
12. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ: Bio-
chemical indicators of B vitamin status in the US population
after folic acid fortification: results from the National Health
and Nutrition Examination Survey 1999–2000.  Am J Clin Nutr
2005, 82(2):442-450.
13. Rader JI, Schneeman BO: Prevalence of neural tube defects,
folate status, and folate fortification of enriched cereal-grain
products in the United States.  Pediatrics 2006,
117(4):1394-1399.
14. Ray , ,  ,  ,  ,   JG, Meier  C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE:
Association of neural tube defects and folic acid food fortifi-
cation in  Canada.  Lancet 2002, 360(9350):2047-8.
15. Houghton LA, Sherwood KL, Pawlosky R, Ito S, O'Connor DL: [6S]-
5-Methyltetrahydrofolate is at least as effective as folic acid
in preventing a decline in blood folate concentrations during
lactation.  Am J Clin Nutr 2006, 83(4):842-850.
16. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM: Folate levels and
neural tube defects. Implications for prevention.  JAMA 1995,
274(21):1698-1702.
17. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM: Mater-
nal plasma folate and vitamin B12 are independent risk fac-
tors for neural tube defects.  Q J Med 1993, 86(11):703-708.
18. Smithells RW, Sheppard S, Schorah CJ: Vitamin deficiencies and
neural tube defects.  Arch Dis Child 1976, 51(12):944-950.
19. van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ: Folate,
homocysteine and neural tube defects: an overview.  Exp Biol
Med (Maywood) 2001, 226(4):243-270.
20. Gibson RS: Assessment of folate and vitamin B12 status.  In
Principles of Nutritional Assessment New York: Oxford University Press;
2005:595-640. 
21. Guinotte CL, Burns MG, Axume JA, Hata H, Urrutia TF, Alamilla A,
McCabe D, Singgih A, Cogger EA, Caudill MA: Methylenetetrahy-
drofolate reductase 677C-->T variant modulates folate sta-
tus response to controlled folate intakes in young women.  J
Nutr 2003, 133(5):1272-1280.
22. Hung J, Yang TL, Urrutia TF, Li R, Perry CA, Hata H, Cogger EA,
Moriarty DJ, Caudill MA: Additional food folate derived exclu-
sively from natural sources improves folate status in young
women with the MTHFR 677 CC or TT genotype.  J Nutr Bio-
chem 2006, 17(11):728-734.
23. Perry CA, Renna SA, Khitun E, Ortiz M, Moriarty DJ, Caudill MA:
Ethnicity and race influence the folate status response to
controlled folate intakes in young women.  J Nutr 2004,
134(7):1786-1792.
24. Shelnutt KP, Kauwell GP, Chapman CM, Gregory JF 3rd, Maneval DR,
Browdy AA, Theriaque DW, Bailey LB: Folate status response to
controlled folate intake is affected by the methylenetetrahy-
drofolate reductase 677C-->T polymorphism in young
women.  J Nutr 2003, 133(12):4107-4111.
25. Yang  TL, Hung Y, Caudill MA, Urrutia TF, Alamilla A, Perry CA, Li R,
Hata H, Cogger EA: A long-term controlled folate feeding
study  in young women supports the validity of the 1.7 mul-
tiplier in the  dietary folate equivalency equation.  J Nutr 2005,
135(5):1139-45.
26. Green TJ, Allen OB, O'Connor DL: A three-day weighed food
record and a semiquantitative food-frequency questionnaire
are valid measures for assessing the folate and vitamin B-12
intakes of women aged 16 to 19 years.  J Nutr 1998,
128(10):1665-1671.
27. Institute of Medicine: Folate.  In Dietary reference intakes for Thiamin,
Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic acid, Biotin
and Choline Washington, DC: The National Academy Press;
1998:196-305. 
28. Canadian Institute of Health Research, Natural Sciences and Engineer-
ing Research Council of Canada, Social Sciences and Humanities
Research Council of Canada. Tri-council policy statement: Ethical
conduct for research involving humans.  Ottawa: Public Works
and Government Services; 1998. 
29. Molloy AM, Scott JM: Microbiological assay for serum, plasma,
and red cell folate using cryopreserved, microtiter plate
method.  Methods Enzymol 1997, 281:43-53.
30. Cole DE, Lehotay DC, Evrovski J: Simplified simultaneous assay
of total plasma homocysteine and methionine by HPLC and
pulsed integrated amperometry.  Clin Chem 1998,
44(1):188-190.
31. Health Canada: Canadian Nutrient File (CNF).  2001 [http://
www.hc-sc.gc.ca/food-aliment/ns-sc/nr-rn/surveillance/cnf-fcen/
e_cnf_downloads.html].
32. United States Department of Agriculture, Agricultural Research Serv-
ice: USDA National Nutrient Databse for Standard Refer-
ence.  2005 [http://www.ars.usda.gov/ba/bhnrc/ndl].
33. Statistics Canada: Median total income, by family type, by prov-
ince and territory. Version 4. August 2006.  2006 [http://
www40.statcan.ca/l01/cst01/famil108a.htm].
34. Herbert V: Development of human folate deficiency.  In Folic
acid metabolism in health and disease Edited by: Picciano MF, Stokstad
EL, Gregory JF, 3rd. New York: Wiley; 1990:195-210. 
35. Clifford AJ, Noceti EM, Block-Joy A, Block T, Block G: Erythrocyte
folate and its response to folic acid supplementation is assay
dependent in women.  J Nutr 2004, 135(1):137-143.
36. Johnston KE, Tamura T: Folate content in commercial white
and whole wheat sandwich breads.  J Agric Food Chem 2004,
52(20):6338-6340.
37. Quinlivan EP, Gregory JF 3rd: Effect of food fortification on folic
acid intake in the United States.  Am J Clin Nutr 2003,
77(1):221-225.
38. Rader JI, Weaver CM, Angyal G: Total folate in enriched cereal-
grain products in the United States following fortification.
Food Chem 2000, 70:275-289.
39. Han YH, Yon M, Hyun TH: Folate intake estimated with an
updated database and its association to blood folate and
homocysteine in  Korean college students.  Eur J Clin Nutr 2005,
59(2):246-54.
40. Sherwood KL, Houghton LA, Tarasuk V, O'Connor DL: One-third
of pregnant and lactating women may not be meeting their
folate requirements from diet alone based on mandated lev-
els of folic acid fortification.  J Nutr 2006, 136(11):2820-2826.
41. Health Canada: Exclusive Breastfeeding Duration – 2004
Health Canada Recommendation.  2004 [http://www.hc-
sc.gc.ca/fn-an/nutrition/child-enfant/infant-nourisson/excl_bf_dur-
dur_am_excl_e.html].
42. American Academy of Pediatrics: Breastfeeding and the use of
human milk.  Pediatrics 2005, 115:496-506.
43. Becker W, Welten D: Under-reporting in dietary surveys –
implications for development of food-based dietary guide-
lines.  Public Health Nutr 2001, 4(2B):683-687.
44. Bingham SA, Cassidy A, Cole TJ, Welch A, Runswick SA, Black AE,
Thurnham D, Bates C, Khaw KT, Key TJ, et al.: Validation of
weighed records and other methods of dietary assessment
using the 24 h urine nitrogen technique and other biological
markers.  Br J Nutr 1995, 73(4):531-550.
45. Black AE, Cole TJ: Biased over- or under-reporting is charac-
teristic of individuals whether over time or by different
assessment methods.  J Am Diet Assoc 2001, 101(1):70-80.
46. Lin Y, Dueker SR, Follett JR, Fadel JG, Arjomand A, Schneider PD,
Miller JW, Green R, Buchholz BA, Vogel JS, et al.: Quantitation of
in vivo human folate metabolism.  Am J Clin Nutr 2004,
80(3):680-691.
47. Suh JR, Herbig AK, Stover PJ: New perspectives on folate catab-
olism.  Annu Rev Nutr 2001, 21:255-282.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2393/7/25/prepubPage 8 of 8
(page number not for citation purposes)
